Literature DB >> 33605218

Retroauricular Abscess in Adults.

Meni Holcberg1, Sabri El-Saied1, Mordechai Kraus1, Daniel M Kaplan1.   

Abstract

OBJECTIVES: To describe the clinical course and outcome of a group of adults who presented with a subperiosteal abscess (SPA) MATERIALS and
METHODS: A retrospective chart review of patients with SPA.
RESULTS: Between 2001 and 2015, 7 such patients-5 men and 2 women-were identified. Their age ranged from 18 to 62 years. Six of them suffered from chronic otitis media (COM) and presented with signs and symptoms of otalgia, pain, and swelling around the mastoid. Five of the patients underwent a previous mastoidectomy for cholesteatoma (4- canal wall down and 1 had canal wall up). One of the non-operated patients had cholesteatoma and the other one had chronic suppurative otitis media without cholesteatoma. One patient developed peripheral facial nerve palsy that resolved after surgery, otherwise, no other intratemporal or intracranial complications were observed. Management included a canal wall down mastoidectomy, abscess drainage, and parenteral wide-spectrum antibiotics. One patient suffered cardiovascular and respiratory comorbidities, requiring the delay of surgery for 6 days. This patient underwent incision and drainage of the abscess before surgery. Pathogens were recognized in 4 of the patients and included Streptococcus pneumoniae, Candida albicans, Staphylococcus aureus, and Corynebacterium.
CONCLUSION: SPA in adults is rare but may be seen in cases of neglected COM, whether previously operated or not. Comorbidities in older population group may require postponing surgery, so immediate incision and drainage may be warranted, as well as post-surgical intensive care.

Entities:  

Year:  2021        PMID: 33605218      PMCID: PMC7901418          DOI: 10.5152/iao.2020.8432

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  11 in total

1.  Can MRI replace a second look operation in cholesteatoma surgery?

Authors:  D Vanden Abeele; E Coen; P M Parizel; P Van de Heyning
Journal:  Acta Otolaryngol       Date:  1999       Impact factor: 1.494

2.  Mastoidectomy cavity obliteration with bioactive glass: a pilot study.

Authors:  Juha Tapio Silvola
Journal:  Otolaryngol Head Neck Surg       Date:  2012-02-27       Impact factor: 3.497

3.  Severe Acute Otitis Media and Acute Mastoiditis in Adults.

Authors:  Anu Laulajainen Hongisto; Jussi Jero; Antti Markkola; Riste Saat; Antti A Aarnisalo
Journal:  J Int Adv Otol       Date:  2016-11-28       Impact factor: 1.017

4.  Mastoid abscess in acute and chronic otitis media.

Authors:  Mazita Ami; Zahirrudin Zakaria; Bee See Goh; Asma Abdullah; Lokman Saim
Journal:  Malays J Med Sci       Date:  2010-10

Review 5.  Pooled analysis of the evidence for open cavity, combined approach and reconstruction of the mastoid cavity in primary cholesteatoma surgery.

Authors:  A T Harris; B Mettias; T H J Lesser
Journal:  J Laryngol Otol       Date:  2016-03       Impact factor: 1.469

6.  Mastoid subperiosteal abscess: a review of 51 cases.

Authors:  Lela Migirov; Arkadi Yakirevitch; Jona Kronenberg
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2005-11       Impact factor: 1.675

7.  Canal wall reconstruction tympanomastoidectomy with mastoid obliteration.

Authors:  Bruce J Gantz; Eric P Wilkinson; Marlan R Hansen
Journal:  Laryngoscope       Date:  2005-10       Impact factor: 3.325

8.  Complications of chronic suppurative otitis media: challenge for a developing country.

Authors:  Fazal I Wahid; Adil Khan; Iftikhar Ahmad Khan
Journal:  Kulak Burun Bogaz Ihtis Derg       Date:  2014 Sep-Oct

9.  Mastoiditis in adults: a 19-year retrospective study.

Authors:  S Palma; R Bovo; A Benatti; C Aimoni; M Rosignoli; M Libanore; A Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-16       Impact factor: 2.503

10.  Mastoid and epitympanic bony obliteration in pediatric cholesteatoma.

Authors:  Jean-Philippe Vercruysse; Bert De Foer; Thomas Somers; Jan W Casselman; Erwin Offeciers
Journal:  Otol Neurotol       Date:  2008-10       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.